Theoretical risks of sustained angiogenic stimulation (promoting vascular supply to undetected pathological tissue) grow proportionally with the duration of use, as cumulative VEGF upregulation exceeds the controlled, injury-localized window intended by short-cycle research protocols
Current recommendations from the American Society for Metabolic and Bariatric Surgery and the Endocrine Society support considering these agents as part of comprehensive management when lifestyle modifications prove insufficient and specific clinical criteria are met
Gut health responds fastest: Patients with SIBO residual symptoms, chronic GI distress, or post-antibiotic gut damage typically report meaningful improvement in GI symptoms within the first 30 days
No reconstitution required
Use your clinics intake, logs, and follow-ups to anchor conversations, and offer patients neutral educational links if they want background on individual nutrients
NMR Meds does not provide medical advice, clinical consultation, or legal guidance
